QQQ0.32%

Trending

XLM12.64%

home Symbol PEPGnews

PEPG
PepGen Inc

1,046

Mkt Cap

$103.75M

Volume

596,083.00

52W High

$7.80

52W Low

$1.01

PE Ratio

-0.86

PEPG Fundamentals

Price

$1.50

Prev Close

$1.50

Open

$1.51

50D MA

$2.13

Beta

0.70

Avg. Volume

1.36M

EPS (Annual)

-$2.12

P/B

0.77

Rev/Employee

$0.00

$143.41

Info

News

all

press releases

PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that data from its PGN-EDODM1 program will be presented in a...

Business Wire

More News

PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

PepGen (PEPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks

PepGen (PEPG) Upgraded to Buy: Here's What You Should Know

PepGen (PEPG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks

PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Business Wire

Pictet Asset Management Holding SA Purchases 871,059 Shares of PepGen, Inc. $PEPG

Pictet Asset Management Holding SA lifted its position in shares of PepGen, Inc. (NASDAQ:PEPG - Free Report) by 181.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,352,424 shares of the company's stock...

MarketBeat

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG...

PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

PR Newswire

PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of PepGen, Inc. (NASDAQ:PEPG - Get Free Report) have received an average recommendation of "Moderate Buy" from the six analysts that are currently covering the stock, MarketBeat Ratings...

MarketBeat

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

PR Newswire

Top 3 Health Care Stocks Which Could Blast Off This Quarter

Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc (VRDN)read more...

Benzinga

...